Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).
Marre M, Shaw J, Brändle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S; LEAD-1 SU study group. Marre M, et al. Diabet Med. 2009 Mar;26(3):268-78. doi: 10.1111/j.1464-5491.2009.02666.x. Diabet Med. 2009. PMID: 19317822 Free PMC article. Clinical Trial.
[Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic -  BIBYII study (observations lasting 24 months)].
Perušičová J, Piťhová P, Haladová I, Diabetologů AP, Acsová D, Bělobrádková J, Belzová A, Berková K, Doležalová B, Dvořáková H, Hejnicová K, Hudcová M, Kallmünzerová D, Krejsová Z, Markofová G, Müllerová H, Owen K, Pelikánová M, Raclavská L, Račická E, Skarpová O, Váchová A, Veselá A, Vyoralová J, Brož J, Edelsberger T, Honka M, Hrdina T, Chmura P, Tosovsky J. Perušičová J, et al. Among authors: honka m. Vnitr Lek. 2013 Apr;59(4):249-55. Vnitr Lek. 2013. PMID: 23711049 Czech.
[Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].
Perusicová J, Haladová I, Pit'hová P, Acsová D, Belobrádková J, Belzová A, Berková K, Dolezalová B, Dvoráková H, Hejnicová K, Hudcová M, Kallmünzerová D, Krejsová Z, Markofová G, Müllerová H, Owen K, Pelikánová M, Raclavská L, Racická E, Skarpová O, Váchová A, Veselá A, Vyoralos J, Broz J, Edelsberger T, Honka M, Hrdina T, Chmura P, Tosovský J. Perusicová J, et al. Among authors: honka m. Vnitr Lek. 2013 Mar;59(3):165-71. Vnitr Lek. 2013. PMID: 23713182 Czech.
Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.
Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, Honka M, Janez A, Krnic M, Lalic N, Martinka E, Rahelic D, Roman G, Tankova T, Várkonyi T, Wolnik B, Zherdova N. Czupryniak L, et al. Among authors: honka m. Diabetes Technol Ther. 2014 Jul;16(7):460-75. doi: 10.1089/dia.2013.0302. Epub 2014 Apr 9. Diabetes Technol Ther. 2014. PMID: 24716890 Free PMC article. Review.
Komentar ke studii EDGE - editorial.
Honka M. Honka M. Vnitr Lek. 2013 Dec;59(12):1039-40. Vnitr Lek. 2013. PMID: 24466605 Czech. No abstract available.
Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?
Schernthaner G, Lotan C, Baltadzhieva-Trendafilova E, Ceponis J, Clodi M, Ducena K, Goncalvesova E, Guja C, Honka M, Janež A, Lalić N, Lehmann R, Nyolczas N, Pauklin P, Rynkiewicz A, Sergienko I, Duvnjak LS. Schernthaner G, et al. Among authors: honka m. Cardiovasc Diabetol. 2018 Nov 21;17(1):145. doi: 10.1186/s12933-018-0788-7. Cardiovasc Diabetol. 2018. PMID: 30463621 Free PMC article.
49 results